Doug Sipp

Right To Try law has a big loophole that’s an opening for bad actors

piggyback-ride-right-to-try-1

There appears to be a big, risky loophole in the relatively new national Right To Try law. Some folks apparently anticipated this problem long ago, but I think most of us weren’t aware of it. Update: More specifically, some law and policy experts were writing about this and other potential loopholes in 2018. I recommend …

Right To Try law has a big loophole that’s an opening for bad actors Read More »

Japan’s dangerous gamble approving unproven stem cells for spinal cord injury

spinal-cord-injury-MRI

There is real hope for treating spinal cord injury with stem cell-based therapies in the future. However, unfortunately regulators in Japan have taken a major misstep in approving a not-ready-for-primetime mesenchymal stem cell (MSC)-based approach to spinal cord injury. Their decision is dangerous and unwise. In a Nature piece (linked to above) by David Cyranoski …

Japan’s dangerous gamble approving unproven stem cells for spinal cord injury Read More »

News bites: CIRM, anti-MSCs, & human eggs from stem cells

human-eggs-from-stem-cells-Saitou

Stem cells are always in the news so what’s up in the last week or two? CIRM News The dialogue over CIRM’s future is picking up a bit of steam. The San Francisco Chronicle did an in-depth piece on CIRM some weeks back and then opined that they didn’t feel supportive of another round of …

News bites: CIRM, anti-MSCs, & human eggs from stem cells Read More »

DOJ cites The Niche blog in suit vs. stem cell clinic firm: what’s scoop?

USA-vs.-California-stem-cell-treatment

It was interesting to see that this blog The Niche was cited in the lawsuit filing by the DOJ in the U.S.A. vs. California Stem Cell Treatment Center, Cell Surgical Network (CSN), et al. case. Yeah, that lawsuit. This suit is part of the DOJ action yesterday that along with the other suit against US Stem Cell …

DOJ cites The Niche blog in suit vs. stem cell clinic firm: what’s scoop? Read More »

Huge clinical trial patient fees allowed by FDA at times, details often secret

Monopoly1-300x2851

I am often critical of for-profit stem cell clinics on this blog for numerous reasons. For instance, one thing that concerns me greatly about these clinics is that they charge patients to get experimental “treatments” that have not been proven to be safe or effective. But as some patients have pointed out to me over the …

Huge clinical trial patient fees allowed by FDA at times, details often secret Read More »

Predatory stem cell clinics are winning: what can we do?

Stem-cell-facelift-comic-e1452454386279

For years I have been working to educate the community about the predatory stem cell clinics out there. These clinics prey on vulnerable patients and their families. The clinics use hope as a marketing tool. A weapon. As the number of such clinics has mushroomed in the US and elsewhere the risk to both patients …

Predatory stem cell clinics are winning: what can we do? Read More »

Stem Cell Person of the Year 2012: Roman Reed

The Knoepfler Lab 2012 Stem Cell Person of the Year is Roman Reed. Congratulations, Roman! Roman made a tremendous difference in 2012 in many ways. One of the most notable was catalyzing the TJ Atchison Spinal Cord Injury Research Act in Alabama, which provides $400,000/year in funding for research. Of course, TJ and many others …

Stem Cell Person of the Year 2012: Roman Reed Read More »

Stem Cell Person of the Year Finalists: time to vote

stem-cell-person-of-the-year

Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for …

Stem Cell Person of the Year Finalists: time to vote Read More »

Centeno and Sipp interview on FDA stem cell oversight

centeno

I have interviewed two folks on the very important US vs. Regenerative Sciences legal case: Dr. Chris Centeno and Doug Sipp. More background on the case can be found at the FDA Law Blog. I thank them both for their time and for sharing their unique perspectives. I have specific rules for these interviews and …

Centeno and Sipp interview on FDA stem cell oversight Read More »